Autoimmune Disease Therapeutics Market in North America is expected to register a CAGR of 3.72% during the forecast period (2019-2025) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report North America Autoimmune Disease Therapeutics Market, published by KBV research, the North America Autoimmune Disease Therapeutics Market would witness market growth of 3.72% CAGR during the forecast period (2019-2025).

The Rheumatic Disease market dominated the North America Autoimmune Disease Therapeutics Market by Indication in 2018, growing at a CAGR of 3.9 % during the forecast period. The Multiple Sclerosis market is expected to witness a CAGR of 3.9% during (2019-2025).

The Retail Pharmacies and Drug Stores market dominated the North America Autoimmune Disease Therapeutics Market by Distribution Channel in 2018, growing at a CAGR of 3.6 % during the forecast period. The Online market is expected to witness a CAGR of 4% during (2019-2025).

The Anti-Inflammatory market dominated the Canada Autoimmune Disease Therapeutics Market by Drug Class in 2018, thereby, achieving a market value of $4,681.3 million by 2025, growing at a CAGR of 4.2 % during the forecast period. The Anti-Hyperglycemics market is expected to witness a CAGR of 4.3% during (2019-2025).

Full Report: https://www.kbvresearch.com/north-america-autoimmune-disease-therapeutics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis AG.

North America Autoimmune Disease Therapeutics Market Segmentation

By Indication

  • Rheumatic Disease
  • Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Other Indications

By Drug Class

  • Anti-Inflammatory
  • Anti-Hyperglycemics
  • NSAIDs
  • Interferons
  • Other Drugs

By Distribution Channel

  • Hospital Pharmacy
  • Online
  • Retail Pharmacies and Drug Stores

By Country

  • US Autoimmune Disease Therapeutics Market
  • Canada Autoimmune Disease Therapeutics Market
  • Mexico Autoimmune Disease Therapeutics Market
  • Rest of North America Autoimmune Disease Therapeutics Market

Companies Profiled

  • ABBOTT Laboratories
  • Bio-Rad Laboratories, Inc.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck and Co., Inc.
  • Bayer AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Novartis AG

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Autoimmune Disease Therapeutics Market Related Reports:

Global Market

Europe Market

Asia Pacific Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.